Nicholas Wettersten

1.2k total citations
43 papers, 581 citations indexed

About

Nicholas Wettersten is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Nephrology. According to data from OpenAlex, Nicholas Wettersten has authored 43 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cardiology and Cardiovascular Medicine, 13 papers in Surgery and 10 papers in Nephrology. Recurrent topics in Nicholas Wettersten's work include Heart Failure Treatment and Management (16 papers), Transplantation: Methods and Outcomes (8 papers) and Renal Transplantation Outcomes and Treatments (7 papers). Nicholas Wettersten is often cited by papers focused on Heart Failure Treatment and Management (16 papers), Transplantation: Methods and Outcomes (8 papers) and Renal Transplantation Outcomes and Treatments (7 papers). Nicholas Wettersten collaborates with scholars based in United States, Japan and Ireland. Nicholas Wettersten's co-authors include Alan S. Maisel, Pranav S. Garimella, Jason M. Duran, Rinaldo Bellomo, Sabine Westphal, Yu Horiuchi, Michael Haase, Christian Albert, Hermann Kuppe and Anja Haase‐Fielitz and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Nicholas Wettersten

36 papers receiving 570 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicholas Wettersten United States 11 319 132 92 73 70 43 581
Carsten Jungbauer Germany 15 444 1.4× 121 0.9× 86 0.9× 64 0.9× 76 1.1× 54 681
Matteo Beltrami Italy 15 426 1.3× 86 0.7× 142 1.5× 49 0.7× 121 1.7× 61 636
Franco Cosmi Italy 12 361 1.1× 124 0.9× 91 1.0× 37 0.5× 59 0.8× 23 534
Matthias K. Freynhofer Austria 18 430 1.3× 61 0.5× 175 1.9× 60 0.8× 58 0.8× 50 732
Emanuele Carbonieri Italy 14 587 1.8× 90 0.7× 84 0.9× 49 0.7× 118 1.7× 32 756
Makoto Suzuki Japan 16 383 1.2× 105 0.8× 144 1.6× 75 1.0× 69 1.0× 62 702
Johny Nicolas United States 11 297 0.9× 91 0.7× 175 1.9× 152 2.1× 96 1.4× 48 632
Vahid Nabavi United States 9 386 1.2× 65 0.5× 239 2.6× 41 0.6× 84 1.2× 15 682
Saïd Kamel France 13 131 0.4× 123 0.9× 154 1.7× 62 0.8× 81 1.2× 27 413
Onur Sinan Deveci Türkiye 14 381 1.2× 58 0.4× 117 1.3× 52 0.7× 55 0.8× 53 608

Countries citing papers authored by Nicholas Wettersten

Since Specialization
Citations

This map shows the geographic impact of Nicholas Wettersten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Wettersten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Wettersten more than expected).

Fields of papers citing papers by Nicholas Wettersten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas Wettersten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Wettersten. The network helps show where Nicholas Wettersten may publish in the future.

Co-authorship network of co-authors of Nicholas Wettersten

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas Wettersten. A scholar is included among the top collaborators of Nicholas Wettersten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas Wettersten. Nicholas Wettersten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garimella, Pranav S., et al.. (2025). Galectin-3 Is Associated With Risk of Cardiovascular and Kidney Outcomes in Ambulatory Veterans. Kidney Medicine. 7(10). 101089–101089.
2.
Ascher, Simon B., Ronit Katz, Michelle M. Estrella, et al.. (2025). Associations of Urine Biomarkers During Ambulatory Acute Kidney Injury With Subsequent Recovery in Kidney Function: Findings From the SPRINT Study. American Journal of Kidney Diseases. 86(2). 155–165. 1 indexed citations
3.
Ascher, Simon B., Ronit Katz, Stein Hallan, et al.. (2025). Plasma Biomarkers of Kidney Tubule Health during Ambulatory AKI and Kidney Function Recovery in SPRINT. Clinical Journal of the American Society of Nephrology. 21(3). 460–470.
5.
Horiuchi, Yu, et al.. (2025). Albuminuria is Associated with Worse Outcomes in Non-Diabetics Hospitalized with Acute Heart Failure. ESC Heart Failure. 12(6). 4369–4378.
6.
Wettersten, Nicholas, Florin Vaida, Yuko Tada, et al.. (2024). Benefit And Risk Of Endomyocardial Biopsy For Heart Transplant Patients In The Contemporary Era. Journal of Cardiac Failure. 30(1). 249–249. 1 indexed citations
7.
Horiuchi, Yu, Alan S. Maisel, Dirk J. van Veldhuisen, et al.. (2024). Significance of an Early Repeat Troponin Measurement Upon Presentation to the Hospital for Acute Heart Failure. Journal of the American Heart Association. 13(18). e034850–e034850. 1 indexed citations
8.
Horiuchi, Yu & Nicholas Wettersten. (2024). Treatment strategies for diuretic resistance in patients with heart failure. Journal of Cardiology. 85(1). 1–7. 2 indexed citations
9.
Vaida, Florin, Nicholas Wettersten, Yuko Tada, et al.. (2023). Incidence of Acute Rejection Compared With Endomyocardial Biopsy Complications for Heart Transplant Patients in the Contemporary Era. Transplantation. 108(5). 1220–1227. 5 indexed citations
10.
Ascher, Simon B., Jarett D. Berry, Ronit Katz, et al.. (2023). Changes in Natriuretic Peptide Levels and Subsequent Kidney Function Decline in SPRINT. American Journal of Kidney Diseases. 83(5). 615–623.e1. 5 indexed citations
11.
Adler, Eric, et al.. (2021). AMYLOID MIMICS: REMEMBERING HYDROXYCHLOROQUINE CARDIOMYOPATHY. Journal of the American College of Cardiology. 77(18). 1924–1924.
12.
Wettersten, Nicholas, Yu Horiuchi, & Alan S. Maisel. (2021). Advancements in biomarkers for cardiovascular disease: diagnosis, prognosis, and therapy. PubMed. 10. 34–34. 5 indexed citations
13.
Wettersten, Nicholas, Ronit Katz, Michael G. Shlipak, et al.. (2021). Urinary Biomarkers and Kidney Outcomes: Impact of Indexing Versus Adjusting for Urinary Creatinine. Kidney Medicine. 3(4). 546–554.e1. 13 indexed citations
14.
Griffin, Matthew D., Veena S. Rao, James H. Fleming, et al.. (2019). Effect on Survival of Concurrent Hemoconcentration and Increase in Creatinine During Treatment of Acute Decompensated Heart Failure. The American Journal of Cardiology. 124(11). 1707–1711. 17 indexed citations
15.
Wettersten, Nicholas, et al.. (2019). Cardiorenal Syndrome. Cardiology Clinics. 37(3). 251–265. 112 indexed citations
16.
Bui, Quan M., Oscar Ö. Braun, Michela Brambatti, et al.. (2018). SIPAT May Predict Clinical Outcomes in Patients With Left Ventricular Assist Device (LVAD). The Journal of Heart and Lung Transplantation. 37(4). S472–S472. 1 indexed citations
17.
Wettersten, Nicholas, et al.. (2018). Successful heart‐kidney transplantation from a Hepatitis C viremic donor to negative recipient: One year of follow‐up. Transplant Infectious Disease. 21(1). 4 indexed citations
18.
19.
Maisel, Alan S., Nicholas Wettersten, Dirk J. van Veldhuisen, et al.. (2016). Neutrophil Gelatinase-Associated Lipocalin for Acute Kidney Injury During Acute Heart Failure Hospitalizations. Journal of the American College of Cardiology. 68(13). 1420–1431. 70 indexed citations
20.
Wettersten, Nicholas, et al.. (2015). Role of Cardiac Troponin Levels in Acute Heart Failure. Cardiac failure review. 1(2). 102–102. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026